These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15674362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
    Zhu HJ, Liu L, Fan L, Zhang LN, Fang C, Zou ZJ, Li JY, Xu W.
    Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells.
    Santidrián AF, González-Gironès DM, Iglesias-Serret D, Coll-Mulet L, Cosialls AM, de Frias M, Campàs C, González-Barca E, Alonso E, Labi V, Viollet B, Benito A, Pons G, Villunger A, Gil J.
    Blood; 2010 Oct 21; 116(16):3023-32. PubMed ID: 20664053
    [Abstract] [Full Text] [Related]

  • 5. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB, Daeninck P, Verburg L, Lee K, Williams G, Israels LG, Mowat MR, Begleiter A.
    Leuk Lymphoma; 1997 Aug 21; 26(5-6):435-49. PubMed ID: 9389352
    [Abstract] [Full Text] [Related]

  • 6. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
    Bosanquet AG, Sturm I, Wieder T, Essmann F, Bosanquet MI, Head DJ, Dörken B, Daniel PT.
    Leukemia; 2002 Jun 21; 16(6):1035-44. PubMed ID: 12040435
    [Abstract] [Full Text] [Related]

  • 7. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
    Tonino SH, Mulkens CE, van Laar J, Derks IA, Suo G, Croon-de Boer F, van Oers MH, Eldering E, Wang JY, Kater AP.
    Leuk Lymphoma; 2015 Jun 21; 56(8):2439-47. PubMed ID: 25511680
    [Abstract] [Full Text] [Related]

  • 8. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.
    Nakajima W, Tanaka N.
    Biochem Biophys Res Commun; 2011 Oct 07; 413(4):643-8. PubMed ID: 21945433
    [Abstract] [Full Text] [Related]

  • 9. p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism.
    Steele AJ, Prentice AG, Hoffbrand AV, Yogashangary BC, Hart SM, Nacheva EP, Howard-Reeves JD, Duke VM, Kottaridis PD, Cwynarski K, Vassilev LT, Wickremasinghe RG.
    Blood; 2008 Nov 01; 112(9):3827-34. PubMed ID: 18682598
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.
    Sanz L, Garcia-Marco JA, Casanova B, de La Fuente MT, García-Gila M, Garcia-Pardo A, Silva A.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):562-7. PubMed ID: 14975737
    [Abstract] [Full Text] [Related]

  • 12. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
    Moon EY, Lerner A.
    Cancer Res; 2002 Oct 15; 62(20):5711-9. PubMed ID: 12384529
    [Abstract] [Full Text] [Related]

  • 13. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM.
    Alonso R, López-Guerra M, Upshaw R, Bantia S, Smal C, Bontemps F, Manz C, Mehrling T, Villamor N, Campo E, Montserrat E, Colomer D.
    Blood; 2009 Aug 20; 114(8):1563-75. PubMed ID: 19541822
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak.
    Melarangi T, Zhuang J, Lin K, Rockliffe N, Bosanquet AG, Oates M, Slupsky JR, Pettitt AR.
    Cell Death Dis; 2012 Aug 16; 3(8):e372. PubMed ID: 22898870
    [Abstract] [Full Text] [Related]

  • 15. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.
    Bannerji R, Kitada S, Flinn IW, Pearson M, Young D, Reed JC, Byrd JC.
    J Clin Oncol; 2003 Apr 15; 21(8):1466-71. PubMed ID: 12697868
    [Abstract] [Full Text] [Related]

  • 16. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L, Gillet N, Stamatopoulos B, Delforge A, Dejeneffe M, Massy M, Meuleman N, Kentos A, Martiat P, Willems L, Bron D.
    Exp Hematol; 2007 Oct 15; 35(10):1527-37. PubMed ID: 17697742
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.
    Olsson A, Norberg M, Okvist A, Derkow K, Choudhury A, Tobin G, Celsing F, Osterborg A, Rosenquist R, Jondal M, Osorio LM.
    Br J Cancer; 2007 Sep 17; 97(6):769-77. PubMed ID: 17726463
    [Abstract] [Full Text] [Related]

  • 18. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.
    Christodoulopoulos G, Fotouhi N, Krajewski S, Reed JC, Alaoui-Jamali M, Panasci L.
    Cancer Lett; 1997 Dec 16; 121(1):59-67. PubMed ID: 9459175
    [Abstract] [Full Text] [Related]

  • 19. A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.
    Zhang LN, Li JY, Xu W.
    Cancer Gene Ther; 2013 Jan 16; 20(1):1-7. PubMed ID: 23175245
    [Abstract] [Full Text] [Related]

  • 20. 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells.
    Steele AJ, Prentice AG, Hoffbrand AV, Yogashangary BC, Hart SM, Lowdell MW, Samuel ER, North JM, Nacheva EP, Chanalaris A, Kottaridis P, Cwynarski K, Wickremasinghe RG.
    Blood; 2009 Aug 06; 114(6):1217-25. PubMed ID: 19515722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.